Completed OBSERVATIONAL NCT02745691

Psychometric Properties of the EORTC QLQ-LC29

An International Phase 4 Field Study for Analyzing the Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Lung Cancer (EORTC QLQ-LC29)

Sponsor: University Hospital Regensburg

Conditions Lung Cancer

Interventions Immunotherapy Radiochemotherapy Surgery Targeted therapy

Updated 9 times since 2017 Last updated: Dec 11, 2019 Started: Apr 1, 2016 Primary completion: Sep 26, 2018 Completion: Sep 26, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lung Cancer, this trial is completed. The trial is conducted by University Hospital Regensburg and has accumulated 9 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jan 2020 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Nov 2018 — Jan 2020 [monthly]

Recruiting

▶ Show 4 earlier versions

Jun 2018 — Nov 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Oct 2017 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Regensburg

Data source: University Hospital Regensburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Regensburg, Germany